Skip to Main Content

Author Details

Zhiyong Wang
Moores Cancer Center, University of California San Diego
2008
61
23
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36537359Co-Overexpression of Two Key Source Genes, <i>OsBMY4</i> and <i>OsISA3</i>, Improves Multiple Key Traits of Rice Seeds.J Agric Food Chem2023
37858338High-throughput chemogenetic drug screening reveals PKC-RhoA/PKN as a targetable signaling vulnerability in GNAQ-driven uveal melanoma.Cell Rep Med2023
37744277CircUCP2 promotes the tumor progression of non-small cell lung cancer through the miR-149/UCP2 pathway.Oncol Res2023
37308665The GPCR-Gα<sub>s</sub>-PKA signaling axis promotes T cell dysfunction and cancer immunotherapy failure.Nat Immunol2023
37476415Comprehensive analysis of the progression mechanisms of CRPC and its inhibitor discovery based on machine learning algorithms.Front Genet2023
36686974The <i>Carthamus tinctorius</i> L. and <i>Lepidium apetalum</i> Willd. Drug Pair Inhibits EndMT through the TGF<i>β</i>1/Snail Signaling Pathway in the Treatment of Myocardial Fibrosis.Evid Based Complement Alternat Med2023
36643277Detection of the peripheral blood antigens and clinical value in recurrent aphthous ulcer: A cross-section study.J Dent Sci2023
35028073Predisposition of hypersensitivity in patients with exfoliative cheilitis.J Dent Sci2022
35756820Direct immunofluorescence and immune function in patients with oral lichen planus.J Dent Sci2022
35756810Identification of key miRNAs and targeted genes involved in the progression of oral squamous cell carcinoma.J Dent Sci2022
35664314NFE2L3 as a Novel Biomarker Associated With IL-2/STAT5/NLRP3 Signaling Pathway in Malignant Pleural Mesothelioma and Other Cancers.Front Genet2022
36451085Tumor mutation burden-related long non-coding RNAs is predictor for prognosis and immune response in pancreatic cancer.BMC Gastroenterol2022
36010978Identification of a Novel Cuproptosis-Related Gene Signature for Prognostic Implication in Head and Neck Squamous Carcinomas.Cancers (Basel)2022
35879302Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC.Nat Commun2022
35086958Microneedle-mediated Intratumoral Delivery of Anti-CTLA-4 Promotes cDC1-dependent Eradication of Oral Squamous Cell Carcinoma with Limited irAEs.Mol Cancer Ther2022
32989819Repurposing disulfiram to induce OSCC cell death by cristae dysfunction promoted autophagy.Oral Dis2021
33603171Cancer-associated fibroblast secretion of PDGFC promotes gastrointestinal stromal tumor growth and metastasis.Oncogene2021
33888713Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer.Nat Commun2021
34725466EGFR Regulates the Hippo pathway by promoting the tyrosine phosphorylation of MOB1.Commun Biol2021
34486492A pan-cancer analysis of the prognostic and immunological role of β-actin (ACTB) in human cancers.Bioengineered2021
34456721Adrenergic Blockade by Nebivolol to Suppress Oral Squamous Cell Carcinoma Growth <i>via</i> Endoplasmic Reticulum Stress and Mitochondria Dysfunction.Front Pharmacol2021
34591642A protein network map of head and neck cancer reveals PIK3CA mutant drug sensitivity.Science2021
34446141Long Non-Coding RNA OIP5-AS1 Inhibits the Proliferation and Migration of Esophageal Squamous Carcinoma Cells by Targeting FOXD1/miR-30a-5p Axis and the Effect of Micro- and Nano-Particles on Targeting Transfection System.J Biomed Nanotechnol2021
34160343MEOX2 serves as a novel biomarker associated with macrophage infiltration in oesophageal squamous cell carcinoma and other digestive system carcinomas.Autoimmunity2021
33993220PD-1 blockade prevents the progression of oral carcinogenesis.Carcinogenesis2021
34155924A Retrospective Study of 52 Patients With Primary Small Cell Carcinoma of the Esophagus Treated With Radical Surgery.Cancer Control2021
34255745Inhibition of mTOR signaling and clinical activity of metformin in oral premalignant lesions.JCI Insight2021
32654232Isorhamnetin induces the paraptotic cell death through ROS and the ERK/MAPK pathway in OSCC cells.Oral Dis2021
32193376YAP1/TAZ-TEAD transcriptional networks maintain skin homeostasis by regulating cell proliferation and limiting KLF4 activity.Nat Commun2020
31722785Dual-functional guanosine-based hydrogel integrating localized delivery and anticancer activities for cancer therapy.Biomaterials2020
33135842Photodynamic therapy in the treatment of oral lichen planus with moderate-to-severe dysplasia: A case report.Dermatol Ther2020
32848210HPV E2, E4, E5 drive alternative carcinogenic pathways in HPV positive cancers.Oncogene2020
32727882Tipifarnib as a Precision Therapy for <i>HRAS</i>-Mutant Head and Neck Squamous Cell Carcinomas.Mol Cancer Ther2020
32205868Muscarinic receptors promote castration-resistant growth of prostate cancer through a FAK-YAP signaling axis.Oncogene2020
32139674Anti-angiogenic effects of VEGF stimulation on endothelium deficient in phosphoinositide recycling.Nat Commun2020
32195010ZBP1 (DAI/DLM-1) promotes osteogenic differentiation while inhibiting adipogenic differentiation in mesenchymal stem cells through a positive feedback loop of Wnt/β-catenin signaling.Bone Res2020
30420444Inhibition of mTOR Signaling and Clinical Activity of Rapamycin in Head and Neck Cancer in a Window of Opportunity Trial.Clin Cancer Res2019
31804466Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4.Nat Commun2019
30187213Correction to: mTOR co-targeting strategies for head and neck cancer therapy.Cancer Metastasis Rev2019
31292160Metformin Inhibits Progression of Head and Neck Squamous Cell Carcinoma by Acting Directly on Carcinoma-Initiating Cells.Cancer Res2019
308943724E-BP1 Is a Tumor Suppressor Protein Reactivated by mTOR Inhibition in Head and Neck Cancer.Cancer Res2019
30858180Genome-wide prediction of synthetic rescue mediators of resistance to targeted and immunotherapy.Mol Syst Biol2019
29985391Assembly and activation of the Hippo signalome by FAT1 tumor suppressor.Nat Commun2018
28790303Prognostic value from integrative analysis of transcription factors c-Jun and Fra-1 in oral squamous cell carcinoma: a multicenter cohort study.Sci Rep2017
28880263LRP6 is identified as a potential prognostic marker for oral squamous cell carcinoma via MALDI-IMS.Cell Death Dis2017
28822012mTOR co-targeting strategies for head and neck cancer therapy.Cancer Metastasis Rev2017
26892607Overexpression of proteasomal activator PA28α serves as a prognostic factor in oral squamous cell carcinoma.J Exp Clin Cancer Res2016
27218663Roles of FGFR in oral carcinogenesis.Cell Prolif2016
27042066The preparation of metal-organic frameworks and their biomedical application.Int J Nanomedicine2016
26882569A synthetic-lethality RNAi screen reveals an ERK-mTOR co-targeting pro-apoptotic switch in PIK3CA+ oral cancers.Oncotarget2016
  • 1 - 50 of 61

Recommended Authors

Hua Li
University of California san francisco
Career Start Year 2013
Number of shared co-authors 12
Gen Li
Research Center for Nano-Biomaterials, Sichuan University
Career Start Year 2013
Number of shared co-authors 1
Stefan Hartmann
University Hospital Wurzburg
Career Start Year 2013
Number of shared co-authors 9
Meixiao Zhan
Zhuhai People's Hospital (Zhuhai Hospital Affiliated with Jinan University)
Career Start Year 2013
Number of shared co-authors 0
Zitong Zhao
School of Pharmacy, Wannan Medical College
Career Start Year 2012
Number of shared co-authors 0
Guo Chen
China Pharmaceutical University
Career Start Year 2009
Number of shared co-authors 3
Pinaki Bose
Cumming School of Medicine, University of Calgary
Career Start Year 2008
Number of shared co-authors 0
Young K Song
National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 3
Myung Woul Han
Ulsan University Hospital, University of Ulsan College of Medicine
Career Start Year 2006
Number of shared co-authors 0
Hye Ryun Kim
Yonsei Cancer Center, Yonsei University College of Medicine
Career Start Year 2005
Number of shared co-authors 6
Fan Zhang
Huaihe Hospital of Henan University
Career Start Year 2004
Number of shared co-authors 0
Sabrina Daniela da Silva
Jewish General Hospital
Career Start Year 2004
Number of shared co-authors 0
Nehad M Alajez
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2004
Number of shared co-authors 0
Yongmei Song
Shandong University of Traditional Chinese Medicine
Career Start Year 2003
Number of shared co-authors 0
Wei Shi
Research Institute, Princess Margaret Cancer Centre
Career Start Year 2002
Number of shared co-authors 0
Wei Zhang
Children's Hospital, Zhejiang University School of Medicine
Career Start Year 2001
Number of shared co-authors 0
Fan Yang
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 0
Hyunseok Kang
Johns Hopkins University
Career Start Year 2000
Number of shared co-authors 12
Lifang Yang
Cancer Research Institute, Central South University
Career Start Year 1998
Number of shared co-authors 0
Erxi Wu
Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin
Career Start Year 1997
Number of shared co-authors 0
Dong Lin
Fujian Medical University Cancer Hospital and Fujian Cancer Hospital
Career Start Year 1996
Number of shared co-authors 1
Sung Tae Kim
Busan Paik Hospital, Inje University
Career Start Year 1996
Number of shared co-authors 0
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 0
Mitchell J Frederick
Baylor College of Medicine
Career Start Year 1995
Number of shared co-authors 9
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Career Start Year 1995
Number of shared co-authors 0
Qimin Zhan
Peking University Cancer Hospital
Career Start Year 1989
Number of shared co-authors 0
Fei-Fei Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 0
Jeffrey N Myers
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 14
Ravindra Uppaluri
Brigham and Women's Hospital
Career Start Year 1988
Number of shared co-authors 9
Wendell G Yarbrough
University of North Carolina at Chapel Hill
Career Start Year 1986
Number of shared co-authors 4

Collaborators

Jorge Silvio Gutkind
Moores Cancer Center, University of California San Diego
Co-authored papers 25
Alfredo A Molinolo
University of California
Co-authored papers 15
Mara Gilardi
Institute of Medical Genetics and Pathology.
Co-authored papers 8
Yusuke Goto
Chiba University Graduate School of Medicine
Co-authored papers 7
Scott M Lippman
Moores Cancer Center, university of california san diego
Co-authored papers 6
Ezra E W Cohen
university of california san diego Health System
Co-authored papers 5
Robert Saddawi-Konefka
Moores Cancer Center, University of California San Diego
Co-authored papers 5
Michael M Allevato
University of Michigan Medical School.
Co-authored papers 5
Joseph A Califano
University of California
Co-authored papers 5
Juan L Callejas-Valera
Cancer Biology Research Center
Co-authored papers 5
Xingyu Wu
Moores Cancer Center, University of California San Diego
Co-authored papers 4
Pablo Tamayo
University of California San Diego
Co-authored papers 3
Olivier Harismendy
University of California
Co-authored papers 3
Nadia Arang
Moores Cancer Center, University of California San Diego
Co-authored papers 3
Farhoud Faraji
University of California San Diego Health
Co-authored papers 3
Ludmil B Alexandrov
Moores Cancer Center, university of california san diego
Co-authored papers 2
Huwate Yeerna
Moores Cancer Center, University of California
Co-authored papers 2
Danielle L Swaney
J. David Gladstone Institutes
Co-authored papers 2
Trey Ideker (CM4AI)
University of California San Diego
Co-authored papers 2
Mizuo Ando
University of Tokyo
Co-authored papers 2
Eytan Ruppin
National Cancer Institute
Co-authored papers 2
Jennifer R Grandis
University of California san francisco
Co-authored papers 2
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers 2
Yardena Samuels
Weizmann Institute of Science
Co-authored papers 2
Jill P Mesirov
University of California San Diego
Co-authored papers 2
Neil E Bhola
Zai Lab (US) LLC
Co-authored papers 1
Jing Yang
Moores Cancer Center, University of California San Diego
Co-authored papers 1
Theresa Guo
Moores Cancer Center, University of California
Co-authored papers 1
Kun-Liang Guan
University of California San Diego
Co-authored papers 1
Akihiro Sakai
Tokai University
Co-authored papers 1
Release 1.2